Compugen (CGEN) Cash from Investing Activities (2009 - 2010)

Compugen's (CGEN) quarterly Cash from Investing Activities came in at $3.0 million in Q4 2010, up 651.12% year-on-year from $394746.3 in Q4 2009, and up 140.55% quarter-over-quarter from -$7.3 million in Q3 2010.

Compugen (CGEN) Cash from Investing Activities (2009 - 2010) Analysis & Trends

Compugen has disclosed Cash from Investing Activities across 2 years of filings, most recently posting $3.0 million for Q4 2010.

  • Cash from Investing Activities for Q4 2010 came in at $3.0 million, up 651.12% year-over-year; the trailing twelve-month figure through Dec 2010 was -$4.9 million (changed N/A YoY), and the FY2025 annual result was $30.0 million, up 164.85% from the prior year.
  • Cash from Investing Activities came in at $3.0 million for Q4 2010 at Compugen, up from -$7.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.0 million in Q4 2010 to a low of -$7.3 million in Q3 2010.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Compugen 189.59 Mn 97.83 Mn 352,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 2.97 Mn
Dec 31, 2010 2.97 Mn
Sep 30, 2010 -7.31 Mn
Sep 30, 2010 -7.31 Mn
Dec 31, 2009 -538,000.00
Dec 31, 2009 -538,000.00
Sep 30, 2009 18,000.00
Sep 30, 2009 18,000.00